Icotinib and rh-endostatin as first line therapy in advanced non small cell line cancer patients harboring activating epidermal growth factor receptor mutations

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 34; no. 15_suppl; p. e20074
Main Authors Zhao, Qiong, Peng, Ling, Chen, Feng, Hong, Zhihai, Mou, Haibo, Wang, Yina, Tang, Yemin, Liu, Junfang
Format Journal Article
LanguageEnglish
Published 20.05.2016
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/JCO.2016.34.15_suppl.e20074